|
|
|
 |
Search published articles |
 |
|
Showing 3 results for Mirhosseini
Nafiseh Kiarostami , Jafar Amani , Abbas Ali Imani Fooladi , Ali Mirhosseini ,
Volume 21, Issue 2 (7-2019)
Abstract
Background and Objective: Breast cancer is one of the most common types of cancer among women. HER-2 molecule as the receptor of tyrosine kinase from the family of epithermal growth factor is a major cause of cancer. The Herceptin protein molecule, which is an anti-HER-2 antibody, can play an important role in the diagnosis and treatment of breast cancer. This study was done to subcloning of Herceptin gene, expression in the prokaryotic system (E.coli) and produce Herceptin recombinant protein for use in the treatment of breast cancer.
Methods: In this descriptive – laboratory study, Herceptin gene from synthesized construct was isolated by enzyme digestion, and then subcloned to the expression vector pET28a. Subcloning of the gene was confirmed using PCR and enzyme digestion. After transferring the vector into E.coli BL21 DE3, expression of the recombinant Herceptin gene was induced by IPTG. The recombinant protein was evaluated by SDS-PAGE and purified with Ni-NTA column chromatography and finally verified by western blotting using anti-histidine antibody. The survival of cells adjacent to recombinant Hercaptin by MTT was investigated.
Results: Following the subcloning of the Herceptin gene, PCR and enzyme digestion, the 741 fragment of the Herceptin gene was confirmed. Confirmation of Herceptin's recombinant protein and its evaluation on SDS-PAGE gel about 27 kDa was done. The recombinant protein was also confirmed with anti-histidine tag. The purified protein adjacent to the SKBR3 cell line was able to block the growth of cancer cells.
Conclusion: Regarding the expersion of HER2 antigen on surface of breast cancer cells, Herceptin can act as antibody blocker and it arrests the growth of breast cancer cells.
Golnaz Mirhosseini , Maryam Tehranipour , Naser Mahdavi Shahri ,
Volume 21, Issue 3 (10-2019)
Abstract
Background and Objective: Multiple Sclerosis (MS) is a neurologic necrotic and chronic illness that causes by demyelination in CNS. One of the common clinical symptoms in MS is cognitive disorders. The most common cognitive defects in patients with MS are reduction of memory and information processing rate hippocampus functions in brain are memory and learning. This study was done to determine the function mechanism of memory discover by study on hippocampus. Nowadays tendency of herbal therapy is increased because of drug's side effects. This study's purpose that is from experimental typ effect of compaind extract of Portulaca olerace, Urtica dioica and Boswellia serrata on memory and number of neurons in CA1 area of hippocampus in induced multiple sclerosis rats.
Methods: In this experimental study 30 male adult rats were randomly allocated into control group, sham group (salin injection), (MS + salin) group, (MS + mixture extract, dose of 200 mg/kg), (MS + mixture extract, dose of 400 mg/kg). MS model was induced by intra hippocampal injection a single dose of ethidium bromide (0.01% ethidium bromide sulotion in 0.9% salin) and in 3 microlitre volume with 1 microlitre in minute rate intraperitoneally. Compaind extract of Portulaca olerace, Urtica dioica and Boswellia serrata were injected as the treatment for 21 days. The shuttle box test was used for evaluation of memory. Dissector method was used for neural density in CA1 of hippocampus. Histopathology method was used for evaluation of the alteration of cells.
Results: Neural density in MS induced group was singnificantly reduced in comparison with control and sham groups (P<0.05). Neural density was singnificantly increased in treatment groups in comparison with MS induced group (P<0.05). Histological results showed that induction of MS caused the disrution of neuron cells in compare to controls, but intraperitonal injection of compaind extract cause neurogenesis in tertment groups. Memory in MS induced group was singnificantly reduced in comparison with control and sham groups (P<0.05), but memory was singnificantly increased in treatment groups in comparison with MS induced group (P<0.05).
Conclusion: Compaind extract of Portulaca olerace, Urtica dioica and Boswellia serrata with dosages of 200 and 400 mg/kg/bw due to neurogenesis and amilioration can effective in memory recovery and neural necrosis in MS disease.
Shahabuddin Mollazaei , Amirabbas Minaeifar , Mahboubeh Mirhosseini , Sadieh Dehghani Firouzabadi ,
Volume 25, Issue 4 (12-2023)
Abstract
Background and Objective: Coronavirus disease 2019 (COVID-19) can lead to organ failure by the occurrence of mechanisms such as increased thrombosis and, subsequently, increased lactate dehydrogenase (LDH). This study was conducted to determine LDH serum levels in COVID-19 patients and the factors affecting their mortality.
Methods: This descriptive-analytical study was conducted on 212 patients (57 males and 155 females) with COVID-19 with a mean age of 49.19±10.6 referring to Imam Ali Hospital in Chabahar, Iran during 2021. After obtaining patients’ informed consent and demographic information, the heparinized peripheral blood sample was taken from them. The LHD levels were determined using an autoanalyzer.
Results: Twenty-nine (13.67%) patients died. The mean LDH serum level of 29 deceased patients (708.420±96.25 U/L) was not statistically significant compared to survivors (640.360±96.80 U/L in 183). The comparison between the surviving and deceased groups showed that 25% of the deceased patients were hospitalized in the intensive care unit (ICU), and 90.90% of the survivors were hospitalized in the internal ward (P<0.05). All the deceased and 85.85% of the survivors were 40 years old and above, and this difference was not statistically significant. Furthermore, 24.56% of the deceased were male, 90.32% of the survivors were female (P<0.05), 22.72% of the deceased had a university education, and 88.69% of the survivors had a diploma or under-diploma education (P<0.05), and 71.42% of the deceased patients had thin, and 91.37% of the survivors were overweight (P<0.05).
Conclusion: There was no difference in the LDH serum levels of the COVID-19 survivors and deceased. The age of 40 years and above, lean and morbidly obese body mass indices, male gender, and the need for hospitalization in the ICU were determined as risk factors.
|
|
